The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A prospective, randomized, blinded, placebo-controlled, phase IIb trial of an autologous tumor lysate + yeast cell wall particles (YCWP) + dendritic cells (DC) vaccine vs unloaded YCWP + DC and embedded phase I/IIa trial with tumor lysate particle only (TLPO) vaccine in stage III and stage IV (resected) melanoma to prevent recurrence.
 
John W Myers
No Relationships to Disclose
 
Garth S Herbert
No Relationships to Disclose
 
Guy T Clifton
No Relationships to Disclose
 
Timothy J Vreeland
No Relationships to Disclose
 
Tommy A Brown
No Relationships to Disclose
 
Kaitlin M. Peace
No Relationships to Disclose
 
Julia M Greene
No Relationships to Disclose
 
Doreen O Jackson
No Relationships to Disclose
 
Diane F Hale
No Relationships to Disclose
 
John S Berry
No Relationships to Disclose
 
Mark B. Faries
Consulting or Advisory Role - Immune Design
Speakers' Bureau - Castle Biosciences; Delcath Systems; Novartis
 
George Earl Peoples
Employment - Cancer Insight; Orbis Health Solutions
Leadership - Cancer Insight; Orbis Health Solutions
Stock and Other Ownership Interests - Cancer Insight; Galena Biopharma; Orbis Health Solutions; Rapamycin Holdings
Consulting or Advisory Role - Galena Biopharma; Rapamycin Holdings
Research Funding - Galena Biopharma; Genentech; Orbis Health Solutions
Patents, Royalties, Other Intellectual Property - Royalties
Travel, Accommodations, Expenses - Cancer Insight; Galena Biopharma; Orbis Health Solutions